BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23349715)

  • 1. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E.
    Namjoshi DR; Martin G; Donkin J; Wilkinson A; Stukas S; Fan J; Carr M; Tabarestani S; Wuerth K; Hancock RE; Wellington CL
    PLoS One; 2013; 8(1):e53529. PubMed ID: 23349715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.
    Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL
    J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1.
    Stukas S; May S; Wilkinson A; Chan J; Donkin J; Wellington CL
    Biochim Biophys Acta; 2012 Mar; 1821(3):536-46. PubMed ID: 21889608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.
    Loane DJ; Washington PM; Vardanian L; Pocivavsek A; Hoe HS; Duff KE; Cernak I; Rebeck GW; Faden AI; Burns MP
    J Neurotrauma; 2011 Feb; 28(2):225-36. PubMed ID: 21175399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Liver X Receptor in AD Pathophysiology.
    Sandoval-Hernández AG; Buitrago L; Moreno H; Cardona-Gómez GP; Arboleda G
    PLoS One; 2015; 10(12):e0145467. PubMed ID: 26720273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE promotes the proteolytic degradation of Abeta.
    Jiang Q; Lee CY; Mandrekar S; Wilkinson B; Cramer P; Zelcer N; Mann K; Lamb B; Willson TM; Collins JL; Richardson JC; Smith JD; Comery TA; Riddell D; Holtzman DM; Tontonoz P; Landreth GE
    Neuron; 2008 Jun; 58(5):681-93. PubMed ID: 18549781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
    Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
    J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons.
    Báez-Becerra C; Filipello F; Sandoval-Hernández A; Arboleda H; Arboleda G
    Neurotox Res; 2018 Apr; 33(3):569-579. PubMed ID: 29297151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.
    Cui X; Chopp M; Zhang Z; Li R; Zacharek A; Landschoot-Ward J; Venkat P; Chen J
    Stroke; 2017 Feb; 48(2):459-467. PubMed ID: 28028143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
    Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
    Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
    Hu Y; Yang Y; Yu Y; Wen G; Shang N; Zhuang W; Lu D; Zhou B; Liang B; Yue X; Li F; Du J; Bu X
    J Med Chem; 2013 Aug; 56(15):6033-53. PubMed ID: 23844653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist GW3965 protects against sepsis by promoting myeloid derived suppressor cells apoptosis in mice.
    Zhang W; Luo M; Zhou Y; Hu J; Li C; Liu K; Liu M; Zhu Y; Chen H; Zhang H
    Life Sci; 2021 Jul; 276():119434. PubMed ID: 33785343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurorestorative benefit of GW3965 treatment of stroke in mice.
    Cui X; Chopp M; Zacharek A; Cui Y; Roberts C; Chen J
    Stroke; 2013 Jan; 44(1):153-61. PubMed ID: 23204055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
    Fitz NF; Cronican A; Pham T; Fogg A; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2010 May; 30(20):6862-72. PubMed ID: 20484628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.
    Riddell DR; Zhou H; Comery TA; Kouranova E; Lo CF; Warwick HK; Ring RH; Kirksey Y; Aschmies S; Xu J; Kubek K; Hirst WD; Gonzales C; Chen Y; Murphy E; Leonard S; Vasylyev D; Oganesian A; Martone RL; Pangalos MN; Reinhart PH; Jacobsen JS
    Mol Cell Neurosci; 2007 Apr; 34(4):621-8. PubMed ID: 17336088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
    van der Hoorn J; Lindén D; Lindahl U; Bekkers M; Voskuilen M; Nilsson R; Oscarsson J; Lindstedt E; Princen H
    Br J Pharmacol; 2011 Apr; 162(7):1553-63. PubMed ID: 21175581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.
    Terwel D; Steffensen KR; Verghese PB; Kummer MP; Gustafsson JÅ; Holtzman DM; Heneka MT
    J Neurosci; 2011 May; 31(19):7049-59. PubMed ID: 21562267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.